The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Antibiotics for Emerging Pathogens
Open accessAbstract
Toward New Scaffolds: Most existing antibiotics are derived from a small number of core molecular structures or scaffolds. As more and more pathogens emerge that are resistant to existing antibiotics, Fischbach and Walsh (p. 1089 ) review why renewed efforts must be made to find not only new antibiotics but new scaffolds. Approaches in the areas of natural products, synthesis, and target-based discovery are all yielding promising antibiotics candidates. The battle against resistance should also involve researching narrow-spectrum antibiotics and using combination therapies to extend the usefulness of drugs with high intrinsic resistance rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Li, J. W.-H., & Vederas, J. C. (2009) · Science · doi:10.1126/science.1168243 · Cited by 2,052
How many antibiotics are produced by the genus Streptomyces ?
Watve, M., Tickoo, R., Jog, M., & Bhole, B. (2001) · Archives of Microbiology · doi:10.1007/s002030100345 · Cited by 923
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655
Gerdes, S. Y., Scholle, M. D., Campbell, J. W., Balázsi, G., Ravasz, E., Daugherty, M. D., Somera, A. L., Kyrpides, N. C., Anderson, I., Gelfand, M. S., et al. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.19.5673-5684.2003 · Cited by 725
Research works printed but not linked: 11
- C. Walsh Antibiotics: Actions Origins Resistance [American Society for Microbiology (ASM) Press Washington DC 2003].
- Nathan C., Goldberg F. M., Nat. Rev. Drug Discovery 4, 887 (2005). · doi:10.1038/nrd1878
- 10.1164/rccm.200801-132OC · doi:10.1164/rccm.200801-132oc
- Neu H. C., Fu K. P., Antimicrob. Agents Chemother. 13, 584 (1978).666290 · doi:10.1128/aac.13.4.584
- 10.1093/jac/10.1.1 · doi:10.1093/jac/10.1.1
- Wenzel S. C., Muller R., Curr. Opin. Drug Discov. Dev. 12, 220 (2009).
- McAlpine J. B., J. Nat. Prod. 72, 566 (2009). · doi:10.1021/np800742z
- 10.1038/ja.2006.74 · doi:10.1038/ja.2006.74
- Baltz R. H., SIM News 55, 186 (2005).
- Singh S. B., Phillips J. W., Wang J., Curr. Opin. Drug Discov. Dev. 10, 160 (2007).
- 10.1073/pnas.0510077103 · DOI
Cited by
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Zhao, X., Wu, H., Guo, B., Dong, R., Qiu, Y., & Ma, P. X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.011 · Cited by 1,971
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Antibacterial activity of silver nanoparticles: A surface science insight
Le Ouay, B., & Stellacci, F. (2015) · Nano Today · doi:10.1016/j.nantod.2015.04.002 · Cited by 1,344
Recent advances in understanding the antibacterial properties of flavonoids
Cushnie, T. P. T., & Lamb, A. J. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.014 · Cited by 1,344
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters
Cimermancic, P., Medema, M. H., Claesen, J., Kurita, K., Wieland Brown, L. C., Mavrommatis, K., Pati, A., Godfrey, P. A., Koehrsen, M., Clardy, J., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.034 · Cited by 981
Self-citationAntibiotics induce redox-related physiological alterations as part of their lethality
Dwyer, D. J., Belenky, P. A., Yang, J. H., MacDonald, I. C., Martell, J. D., Takahashi, N., Chan, C. T. Y., Lobritz, M. A., Braff, D., Schwarz, E. G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401876111 · Cited by 948
The Ecology and Evolution of Microbial Competition
Ghoul, M., & Mitri, S. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.011 · Cited by 917
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Richter, M. F., Drown, B. S., Riley, A. P., Garcia, A., Shirai, T., Svec, R. L., & Hergenrother, P. J. (2017) · Nature · doi:10.1038/nature22308 · Cited by 891
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli
Cui, Y., Zhao, Y., Tian, Y., Zhang, W., Lü, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.057 · Cited by 862
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Antibiotics produced by Streptomyces
de Lima Procópio, R. E., da Silva, I. R., Martins, M. K., de Azevedo, J. L., & de Araújo, J. M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.08.014 · Cited by 735
Plant-Derived Antimicrobial Compounds: Alternatives to Antibiotics
Savoia, D. (2012) · Future Microbiology · doi:10.2217/fmb.12.68 · Cited by 601
Zhao, X., Li, P., Guo, B., & Ma, P. X. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.08.006 · Cited by 570
Nanoparticle–Biofilm Interactions: The Role of the EPS Matrix
Fulaz, S., Vitale, S., Quinn, L., & Casey, E. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.07.004 · Cited by 562
Understanding the mechanisms of faecal microbiota transplantation
Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 561
Cock, I., Cheesman, M., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews · doi:10.4103/phrev.phrev_21_17 · Cited by 550
Co-occurrence of antibiotic and metal resistance genes revealed in complete genome collection
Li, L.-G., Xia, Y., & Zhang, T. (2017) · The ISME Journal · doi:10.1038/ismej.2016.155 · Cited by 528
Current Developments of Coumarin Compounds in Medicinal Chemistry
Peng, X.-M., L.V. Damu, G., & He Zhou, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319210013 · Cited by 504
Computational approaches to natural product discovery
Medema, M. H., & Fischbach, M. A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1884 · Cited by 493
Self-citationQu, J., Zhao, X., Ma, P. X., & Guo, B. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.018 · Cited by 468
Natural Products Version 2.0: Connecting Genes to Molecules
Walsh, C. T., & Fischbach, M. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909118a · Cited by 468
Self-citationActinomycetes: Still a source of novel antibiotics
Genilloud, O. (2017) · Natural Product Reports · doi:10.1039/c7np00026j · Cited by 465
Angel Ezhilarasi, A., Judith Vijaya, J., Kaviyarasu, K., John Kennedy, L., Ramalingam, R. J., & Al-Lohedan, H. A. (2018) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2018.01.023 · Cited by 451
Imamovic, L., & Sommer, M. O. A. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006609 · Cited by 444
Molecular mechanisms of antibiotic resistance
Wright, G. D. (2011) · Chemical Communications · doi:10.1039/c0cc05111j · Cited by 443
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
Diversity-oriented synthesis: producing chemical tools for dissecting biology
O' Connor, C. J., Beckmann, H. S. G., & Spring, D. R. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35023h · Cited by 434
Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing
Ando, H., Lemire, S., Pires, D. P., & Lu, T. K. (2015) · Cell Systems · doi:10.1016/j.cels.2015.08.013 · Cited by 426
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Kang, M., Zhou, C., Wu, S., Yu, B., Zhang, Z., Song, N., Lee, M. M. S., Xu, W., Xu, F.-J., Wang, D., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b07162 · Cited by 414
Carbon Dot-Based Platform for Simultaneous Bacterial Distinguishment and Antibacterial Applications
Yang, J., Zhang, X., Ma, Y.-H., Gao, G., Chen, X., Jia, H.-R., Li, Y.-H., Chen, Z., & Wu, F.-G. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10398 · Cited by 409
Role of Pore-Forming Toxins in Bacterial Infectious Diseases
Los, F. C. O., Randis, T. M., Aroian, R. V., & Ratner, A. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00052-12 · Cited by 402
Application of metagenomics in the human gut microbiome
Wang, W.-L., Xu, S.-Y., Ren, Z.-G., Tao, L., Jiang, J.-W., & Zheng, S.-S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i3.803 · Cited by 397
Antibiotics as Signal Molecules
Romero, D., Traxler, M. F., López, D., & Kolter, R. (2011) · Chemical Reviews · doi:10.1021/cr2000509 · Cited by 390
Traxler, M. F., Watrous, J. D., Alexandrov, T., Dorrestein, P. C., & Kolter, R. (2013) · mBio · doi:10.1128/mbio.00459-13 · Cited by 381
Prospects for new antibiotics: a molecule-centered perspective
Walsh, C. T., & Wencewicz, T. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 372
Self-citationAyaz, M., Ullah, F., Sadiq, A., Ullah, F., Ovais, M., Ahmed, J., & Devkota, H. P. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.050 · Cited by 359
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
Abed, N., & Couvreur, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.009 · Cited by 358
Chen, H., Cheng, J., Ran, L., Yu, K., Lu, B., Lan, G., Dai, F., & Lu, F. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.090 · Cited by 358
Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review
El-Beltagi, H. S., Mohamed, A. A., Mohamed, H. I., Ramadan, K. M. A., Barqawi, A. A., & Mansour, A. T. (2022) · Marine Drugs · doi:10.3390/md20060342 · Cited by 354
A platform for the discovery of new macrolide antibiotics
Seiple, I. B., Zhang, Z., Jakubec, P., Langlois-Mercier, A., Wright, P. M., Hog, D. T., Yabu, K., Allu, S. R., Fukuzaki, T., Carlsen, P. N., et al. (2016) · Nature · doi:10.1038/nature17967 · Cited by 351
Fang, H., Wang, H., Cai, L., & Yu, Y. (2015) · Environmental Science & Technology · doi:10.1021/es504157v · Cited by 350
The advanced role of carbon quantum dots in nanomedical applications
Devi, P., Saini, S., & Kim, K.-H. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.059 · Cited by 349
Marrero, J., Rhee, K. Y., Schnappinger, D., Pethe, K., & Ehrt, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000715107 · Cited by 347
Two major medicinal honeys have different mechanisms of bactericidal activity
Kwakman, P. H. S., te Velde, A. A., de Boer, L., Vandenbroucke-Grauls, C. M. J. E., & Zaat, S. A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017709 · Cited by 342
The antimicrobial potential of Streptomyces from insect microbiomes
Chevrette, M. G., Carlson, C. M., Ortega, H. E., Thomas, C., Ananiev, G. E., Barns, K. J., Book, A. J., Cagnazzo, J., Carlos, C., Flanigan, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08438-0 · Cited by 340
Targeting the “Cytokine Storm” for Therapeutic Benefit
D'Elia, R. V., Harrison, K., Oyston, P. C., Lukaszewski, R. A., & Clark, G. C. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00636-12 · Cited by 324
Xu, H., Fang, Z., Tian, W., Wang, Y., Ye, Q., Zhang, L., & Cai, J. (2018) · Advanced Materials · doi:10.1002/adma.201801100 · Cited by 318
Ribosome biogenesis in disease: new players and therapeutic targets
Jiao, L., Liu, Y., Yu, X.-Y., Pan, X., Zhang, Y., Tu, J., Song, Y.-H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01285-4 · Cited by 313
Ge, C., Wu, R., Chong, Y., Fang, G., Jiang, X., Pan, Y., Chen, C., & Yin, J. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801484 · Cited by 300
High-throughput platform for the discovery of elicitors of silent bacterial gene clusters
Seyedsayamdost, M. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400019111 · Cited by 298
In silico repositioning of approved drugs for rare and neglected diseases
Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288
Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., & Miller, J. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-09 · Cited by 286
Towards an integrated model of bacterial conjugation
Cabezón, E., Ripoll-Rozada, J., Peña, A., de la Cruz, F., & Arechaga, I. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12085 · Cited by 286
Silica Nanopollens Enhance Adhesion for Long-Term Bacterial Inhibition
Song, H., Ahmad Nor, Y., Yu, M., Yang, Y., Zhang, J., Zhang, H., Xu, C., Mitter, N., & Yu, C. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b00243 · Cited by 286
Abedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Unraveling the Physiological Complexities of Antibiotic Lethality
Dwyer, D. J., Collins, J. J., & Walker, G. C. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124712 · Cited by 280
Exploring phytochemicals for combating antibiotic resistance in microbial pathogens
Khare, T., Anand, U., Dey, A., Assaraf, Y. G., Chen, Z.-S., Liu, Z., & Kumar, V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720726 · Cited by 281
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
Hong, D. J., Bae, I. K., Jang, I.-H., Jeong, S. H., Kang, H.-K., & Lee, K. (2015) · Infection & Chemotherapy · doi:10.3947/ic.2015.47.2.81 · Cited by 271
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & Fusetani, N. (2011) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cbpc.2010.08.008 · Cited by 270
Li, P., Zhou, C., Rayatpisheh, S., Ye, K., Poon, Y. F., Hammond, P. T., Duan, H., & Chan‐Park, M. B. (2012) · Advanced Materials · doi:10.1002/adma.201104186 · Cited by 268
Antimicrobial activity of essential oils
Murbach Teles Andrade, B. F., Nunes Barbosa, L., da Silva Probst, I., & Fernandes Júnior, A. (2014) · Journal of Essential Oil Research · doi:10.1080/10412905.2013.860409 · Cited by 265
Bacterial cell wall assembly: still an attractive antibacterial target
Bugg, T. D. H., Braddick, D., Dowson, C. G., & Roper, D. I. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.12.006 · Cited by 265
Hu, Y., Chen, J., Hu, G., Yu, J., Zhu, X., Lin, Y., Chen, S., & Yuan, J. (2015) · Marine Drugs · doi:10.3390/md13010202 · Cited by 260
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Self-citationMultifunctional Antimicrobial Biometallohydrogels Based on Amino Acid Coordinated Self‐Assembly
Song, J., Yuan, C., Jiao, T., Xing, R., Yang, M., Adams, D. J., & Yan, X. (2020) · Small · doi:10.1002/smll.201907309 · Cited by 259
Xi, Y., Ge, J., Guo, Y., Lei, B., & Ma, P. X. (2018) · ACS Nano · doi:10.1021/acsnano.8b01152 · Cited by 257
Chalcone derivatives and their antibacterial activities: Current development
Xu, M., Wu, P., Shen, F., Ji, J., & Rakesh, K. P. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103133 · Cited by 254
Liu, C., Zhang, M., Geng, H., Zhang, P., Zheng, Z., Zhou, Y., & He, W. (2021) · Applied Catalysis B: Environmental · doi:10.1016/j.apcatb.2021.120317 · Cited by 236
Systems-level antimicrobial drug and drug synergy discovery
Roemer, T., & Boone, C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1205 · Cited by 159
Wallock-Richards, D., Doherty, C. J., Doherty, L., Clarke, D. J., Place, M., Govan, J. R. W., & Campopiano, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112726 · Cited by 151
Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment
Ross-Gillespie, A., Weigert, M., Brown, S. P., & Kümmerli, R. (2014) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eou003 · Cited by 104
“Consequently, the therapy will lose efficacy [1, 2].”
Brisbois, E. J., Davis, R. P., Jones, A. M., Major, T. C., Bartlett, R. H., Meyerhoff, M. E., & Handa, H. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01839g · Cited by 101
Chang, W., Liu, J., Zhang, M., Shi, H., Zheng, S., Jin, X., Gao, Y., Wang, S., Ji, A., & Lou, H. (2018) · Nature Communications · doi:10.1038/s41467-018-07633-9 · Cited by 91
Carlson-Banning, K. M., Chou, A., Liu, Z., Hamill, R. J., Song, Y., & Zechiedrich, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069646 · Cited by 73
“Repurposing already approved therapies for alternative uses saves both time and money [7].”
BackgroundInfluentialNucleophilic 1,4-Additions for Natural Product Discovery
Cox, C. L., Tietz, J. I., Sokolowski, K., Melby, J. O., Doroghazi, J. R., & Mitchell, D. A. (2014) · ACS Chemical Biology · doi:10.1021/cb500324n · Cited by 63
Degradation of Sulfamethoxazole Using Iron-Doped Titania and Simulated Solar Radiation
Tsiampalis, A., Frontistis, Z., Binas, V., Kiriakidis, G., & Mantzavinos, D. (2019) · Catalysts · doi:10.3390/catal9070612 · Cited by 46
“Due to the impressive results of penicillin, a large part of the scientific community was involved in the production of new synthetic antibiotics that could further improve the quality of human life [2].”
BackgroundBonde, M., Højland, D. H., Kolmos, H. J., Kallipolitis, B. H., & Klitgaard, J. K. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02255.x · Cited by 34
Metadata
- Authors
- Fischbach, M. A., & Walsh, C. T.
- Venue
- Science
- Published
- 2009-08-28
- Volume
- 325
- Issue
- 5944
- Pages
- 1089-1093
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1970798262
- Cited by
- 1,777
- References
- 42
- FWCI
- 73.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.